Nearly fifteen years after the initial discovery of MXenes—a prolific class of two-dimensional (2D) transition metal carbides and nitrides—the researchers…
Read More
Teva Pharmaceutical Secures FDA Approval for Ponlimsi Biosimilar to Prolia, Advances Xolair Biosimilar Applications in US and EU
Teva Pharmaceutical has announced a significant milestone in its biosimilar portfolio with the U.S. Food and Drug Administration (FDA) granting…
Read More
Leading Nanomedicine Experts Unveil Definitive Guide to Cancer Applications, Addressing Translational Hurdles and Charting Future Innovations
Liverpool John Moores University (LJMU) Professor of Nanomedicine, Imran Saleem, and Qassim University Professor of Pharmaceutics, Ahmed AH Abdellatif, long-time…
Read More
